Upcoming System Maintenance

Notice: Promega will be performing essential system updates January 21–25.

Order processing and shipping will pause starting January 21 at 4:00 PM CST and resume on January 26.
Please plan to order in advance for any products needed during this timeframe.

Please contact Customer Service with any questions.

Dr. Xuping Xie, University of Texas Medical Branch

NanoLuc® Luciferase Reporter Viruses

Dr. Xie’s group constructed a NanoLuc® SARS-CoV-2 reporter virus and screened a broad selection of existing anti-infective drugs. They identified several agents, including remdesivir, as potent, selective inhibitors of SARS-CoV-2. They also used the reporter virus to measure neutralizing antibody levels in COVID-19 patients.

Learn More

NanoLuc® Luciferase: One Enzyme, Endless Capabilities

Go to Technology Page

NanoLuc® Technologies Advance Virology Research

View Products